According to CRISPR Therapeutics's latest financial reports the company's current earnings are C$0.20 Billion. In 2023 the company made an earning of -C$0.22 Billion, an increase over its 2022 earnings that were of -C$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.